ANDA Abbreviated New Drug Applications

Vesta Pharmaceuticals has on-staff industry experts in the field of Abbreviated New Drug Applications (ANDA).  ANDA is the FDA’s expedited process to approve the generic pharmaceuticals that compete with innovator drugs coming off patent protection.  ANDA eliminates the need for costly clinical trials as long as the generic drug is scientifically proven as bioequivalent to the original drug.  Vesta Pharmaceuticals has experienced, dedicated experts devoted to guiding you every step of the way through the ANDA process.   

Consumers and governments alike are pressuring the pharmaceutical industry to produce more high quality, effective prescription medications at significantly reduced prices; therefore, demand for generic prescriptions will continue to skyrocket.   Vesta Pharmaceuticals is positioned perfectly to partner with your company to develop, manufacture, and deliver the high-quality generic drugs you need to propel your business’ growth.

Vesta will manufacture your generic drugs in our FDA-registered facility with the utmost consistency and quality, and we will deliver your product exactly when you need it.



 

  CLICK HERE: To View Our VESTA® Brochure

Home | Who We Are | Dietary Contract Manufacturing | Industrial Use Products | Research & Development
International Distribution Partner Program | Career Opportunities | Contact Us